Assessing the potential cost-effectiveness of a gene therapy for the treatment of hemophilia A.

MLA

Cook, Keziah, et al. “Assessing the Potential Cost-Effectiveness of a Gene Therapy for the Treatment of Hemophilia A.” Journal of Medical Economics, vol. 23, no. 5, May 2020, pp. 501–12. EBSCOhost, https://doi.org/10.1080/13696998.2020.1721508.

APA

Cook, K., Forbes, S. P., Adamski, K., Ma, J. J., Chawla, A., & Garrison, L. P., Jr. (2020). Assessing the potential cost-effectiveness of a gene therapy for the treatment of hemophilia A. Journal of Medical Economics, 23(5), 501–512. https://doi.org/10.1080/13696998.2020.1721508

Chicago

Cook, Keziah, Shaun P Forbes, Kelly Adamski, Janice J Ma, Anita Chawla, and Louis P Garrison Jr. 2020. “Assessing the Potential Cost-Effectiveness of a Gene Therapy for the Treatment of Hemophilia A.” Journal of Medical Economics 23 (5): 501–12. doi:10.1080/13696998.2020.1721508.